Skip to main content
. 2017 Jan 10;8(7):12186–12193. doi: 10.18632/oncotarget.14575

Table 2. Univariate and multivariate analyses of overall survival in NSCLC patients.

Variable Univariate Multivariate
HR (95% CI) P HR (95% CI) P
Gender 0.537
 Female 1.000
 Male 1.120 (0.781-1.605)
Age (y) 0.174
 ≤60 1.000
 >60 1.297 (0.892-1.885)
Histologic type 0.084
 AC 1.000
 SC 0.669 (0.424-1.055)
Differentiation 0.486
 Well 1.000
 Moderate 1.256 (0.846-1.863)
 Poor 1.237 (0.736-2.078)
pT category <0.001 0.038
 T1-T2 1.000 1.000
 T3-T4 2.198 (1.411-3.424) 1.624 (1.028-2.563)
pN category <0.001 0.006
 Negative 1.000 1.000
 Positive 2.253 (1.556-3.240) 1.726 (1.171-2.543)
Distant metastasis <0.001 <0.001
 Negative 1.000 1.000
 Positive 6.583 (3.158-13.725) 3.920 (1.829-8.400)
TNM stage <0.001
 I-II 1.000
 III-IV 3.847 (2.503-5.913)
FSIP status <0.001 0.001
 Negative 1.000 1.000
 Positive 2.176 (1.489-3.180) 1.876 (1.274-2.764)
Ki67 status 0.006 0.019
 Negative 1.000 1.000
 Positive 1.769 (1.179-2.654) 1.629 (1.082-2.453)

Abbreviation, AC: adenocarcinoma; FSIP1: fibrous sheath interacting protein 1; SC: squamous carcinoma.